Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of circulating plasma DNA in gastric cancer

27 Jan 2016

Abstract excerpt

With the progression of molecular techniques, the detection of circulating plasma DNA (cpDNA) is clinically feasible. However, the role of the cpDNA levels in gastric cancer is not well understood. This study assessed the mutational profile in primary tumors and clarified the clinical utility of quantitative and qualitative cpDNA alterations in 277 patients with advanced gastric cancer. The concentrations of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26815009
DOI: 10.1002/ijc.30018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of circulating plasma DNA in gastric cancerPMID 26815009Read ↗

Clinical applications and perspectives of circulating tumor DNA in gastric cancerSemantic proximity Read ↗

Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer.Semantic proximity Read ↗

Monitoring gastric cancer progression with circulating tumour DNASemantic proximity Read ↗

The Role of ctDNA in Gastric CancerSemantic proximity Read ↗

Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.Semantic proximity Read ↗

Development of circulating tumour DNA analysis for gastrointestinal cancersSemantic proximity Read ↗

Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersSemantic proximity Read ↗

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitorsSemantic proximity Read ↗

Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.Semantic proximity Read ↗

New blood markers detection technology: A leap in the diagnosis of gastric cancer.Semantic proximity Read ↗

Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNASemantic proximity Read ↗

Endoscopic liquid biopsies of gastric fluid in a large patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.